HTG Molecular Diagnostics Inc (STU:65H)
€ 0.242 0 (0%) Market Cap: 1,000.00 Enterprise Value: -2.44 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 37/100

Q1 2019 HTG Molecular Diagnostics Inc Earnings Call Transcript

May 09, 2019 / 08:30PM GMT
Release Date Price: €388.89 (-0.78%)
Operator

Good day, and welcome to the HTG Molecular Diagnostics, Inc. First Quarter 2019 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Monique Kosse. Please go ahead, ma'am.

Monique Kosse
LifeSci Advisors, LLC - MD

Thank you, Dory. Earlier today, HTG released financial results for the quarter ended March 31, 2019.

Before we begin the call, let me remind you that the company's remarks include forward-looking statements within the meaning of federal securities laws, including potential go-forward decisions by PDP customers, recent product launch expected instrument placements in Europe, expansion of the company's relationship with Illumina, product development efforts, possible additional collaborations with pharma customers and revenue expectations for the full year 2019.

These forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond HTG's control that may cause HTG's actual circumstances, events or results to differ materially from

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot